Patents Assigned to ByHeart, Inc.
  • Publication number: 20220168399
    Abstract: Formulations having a protein component, in which the protein contains one or more digestion-aiding proteins, and/or one or more immunoprotective proteins. The formulations may also contain a fat component, a carbohydrate component, and vitamins and minerals. These formulations can be used to provide nutritional support to a subject, either as dietary supplements or as a primary source of nutrition, such as for an infant formula.
    Type: Application
    Filed: December 10, 2021
    Publication date: June 2, 2022
    Applicant: ByHeart, Inc.
    Inventors: Ron Belldegrun, Mia Funt
  • Patent number: 11197917
    Abstract: Formulations having a protein component, in which the protein contains one or more digestion-aiding proteins, and/or one or more immunoprotective proteins. The formulations may also contain a fat component, a carbohydrate component, and vitamins and minerals. These formulations can be used to provide nutritional support to a subject, either as dietary supplements or as a primary source of nutrition, such as for an infant formula.
    Type: Grant
    Filed: December 1, 2017
    Date of Patent: December 14, 2021
    Assignee: ByHeart, Inc.
    Inventors: Ron Belldegrun, Mia Funt
  • Publication number: 20210138042
    Abstract: Formulations having a protein component, in which the protein contains one or more digestion-aiding proteins, and one or more immunoprotective proteins. The ratio by weight of the one or digestion-aiding proteins to the one or more immunoprotective proteins may be about 12:1 to about 1:1. The formulations may also contain a fat component, a carbohydrate component, and vitamins and minerals. These formulations can be used to provide nutritional support to a subject, either as dietary supplements or as a primary source of nutrition, such as for an infant formula. The formulations may also be used to promote or induce proliferation of intestinal cells, promote or induce differentiation of intestinal cells, prevent or inhibit growth of enteropathogenic Escherichia coli in the digestive system of a subject, prevent or inhibit bacterial growth in the intestinal lumen, increase interleukin-18 secretion by intestinal cells, or increase intestinal immunity.
    Type: Application
    Filed: January 22, 2021
    Publication date: May 13, 2021
    Applicant: ByHeart, Inc.
    Inventors: Ron Belldegrun, Mia Funt